Genmab A/S
Patents, Design & Utilities
Last updated:
List of all Genmab A/S patents 89 in total
| Status | Patent |
|---|---|
Application | Utility: INERT FORMAT Filling date: 6 Sep 2025 Issue date: 22 Oct 2020 |
Application | Utility: Human Monoclonal Antibodies Against CD20 Filling date: 6 Sep 2025 Issue date: 8 Oct 2020 |
Grant | Utility: Monoclonal antibodies against HER2 epitope Filling date: 6 Sep 2025 Issue date: 6 Oct 2020 |
Application | Utility: ANTIBODIES AGAINST CD38 FOR TREATMENT OF MULTIPLE MYELOMA Filling date: 6 Sep 2025 Issue date: 10 Sep 2020 |
Grant | Utility: Antibodies binding AXL Filling date: 6 Sep 2025 Issue date: 8 Sep 2020 |
Application | Utility: ANTIBODIES Filling date: 6 Sep 2025 Issue date: 3 Sep 2020 |
Application | Utility: BISPECIFIC ANTIBODIES AGAINST HER2 AND CD3 Filling date: 6 Sep 2025 Issue date: 27 Aug 2020 |
Grant | Utility: Stable IgG4 antibodies Filling date: 6 Sep 2025 Issue date: 25 Aug 2020 |
Application | Utility: HETERODIMERIC ANTIBODY FC-CONTAINING PROTEINS AND METHODS FOR PRODUCTION THEREOF Filling date: 6 Sep 2025 Issue date: 20 Aug 2020 |
Application | Utility: MULTISPECIFIC ANTIBODIES AGAINST CD40 AND CD137 Filling date: 6 Sep 2025 Issue date: 6 Aug 2020 |
Application | Utility: ANTIBODY-DRUG CONJUGATE LYOPHILISED FORMULATION Filling date: 6 Sep 2025 Issue date: 6 Aug 2020 |
Application | Utility: ANTIBODIES AGAINST PD-L1 Filling date: 6 Sep 2025 Issue date: 30 Jul 2020 |
Grant | Utility: Human monoclonal antibodies against CD25 Filling date: 6 Sep 2025 Issue date: 7 Jul 2020 |
Application | Utility: BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20 Filling date: 6 Sep 2025 Issue date: 25 Jun 2020 |
Application | Utility: HUMANIZED OR CHIMERIC CD3 ANTIBODIES Filling date: 6 Sep 2025 Issue date: 25 Jun 2020 |
Application | Utility: ANTIBODIES BINDING AXL Filling date: 6 Sep 2025 Issue date: 4 Jun 2020 |
Application | Utility: VARIANTS OF CD38 ANTIBODY AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 28 May 2020 |
Application | Utility: BINDING AGENTS BINDING TO PD-L1 AND CD137 AND USE THEREOF Filling date: 6 Sep 2025 Issue date: 28 May 2020 |
Application | Utility: MODULATION OF COMPLEMENT-DEPENDENT CYTOTOXICITY THROUGH MODIFICATIONS OF THE C-TERMINUS OF ANTIBODY HEAVY CHAINS Filling date: 6 Sep 2025 Issue date: 30 Apr 2020 |
Application | Utility: HUMANIZED OR CHIMERIC CD3 ANTIBODIES Filling date: 6 Sep 2025 Issue date: 23 Apr 2020 |
Application | Utility: COMBINATION TREATMENT OF CD38-EXPRESSING TUMORS Filling date: 6 Sep 2025 Issue date: 16 Apr 2020 |
Grant | Utility: Lyophilized anti-tissue factor antibody-drug conjugates Filling date: 6 Sep 2025 Issue date: 14 Apr 2020 |
Grant | Utility: Heterodimeric antibody Fc-containing proteins and methods for production thereof Filling date: 6 Sep 2025 Issue date: 24 Mar 2020 |
Grant | Utility: Inert format Filling date: 6 Sep 2025 Issue date: 17 Mar 2020 |
Application | Utility: AGONISTIC TNF RECEPTOR BINDING AGENTS Filling date: 6 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: MONOCLONAL ANTIBODIES AGAINST C-MET Filling date: 6 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: MULTISPECIFIC ANTIBODIES AGAINST CD40 AND CD137 Filling date: 6 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: PRODUCTION OF HETERODIMERIC PROTEINS Filling date: 6 Sep 2025 Issue date: 13 Feb 2020 |
Grant | Utility: Bispecific antibodies against CD3 and CD20 Filling date: 6 Sep 2025 Issue date: 28 Jan 2020 |
Application | Utility: VARIANTS OF CD38 ANTIBODY AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 16 Jan 2020 |
Grant | Utility: Antibodies binding AXL Filling date: 6 Sep 2025 Issue date: 24 Dec 2019 |
Grant | Utility: Antibodies binding AXL Filling date: 6 Sep 2025 Issue date: 10 Dec 2019 |
Application | Utility: MULTISPECIFIC ANTIGEN-BINDING MOLECULE WITH IMPROVED INTERNALIZATION CHARACTERISTICS Filling date: 6 Sep 2025 Issue date: 21 Nov 2019 |
Grant | Utility: Methods of inducing T cell activation by administering an antibody comprising CD40 and 4-1BB (CD137) binding domains Filling date: 6 Sep 2025 Issue date: 29 Oct 2019 |
Application | Utility: HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR Filling date: 6 Sep 2025 Issue date: 17 Oct 2019 |
Application | Utility: HUMANIZED OR CHIMERIC CD3 ANTIBODIES Filling date: 6 Sep 2025 Issue date: 19 Sep 2019 |
Application | Utility: ANTIBODIES BINDING AXL Filling date: 6 Sep 2025 Issue date: 12 Sep 2019 |
Grant | Utility: Humanized or chimeric CD3 antibodies Filling date: 6 Sep 2025 Issue date: 10 Sep 2019 |
Application | Utility: NEW DOSAGE REGIMENS FOR ANTIBODY DRUG CONJUGATES BASED ON ANTI-AXL ANTIBODIES Filling date: 6 Sep 2025 Issue date: 1 Aug 2019 |
Showing 50 to 89 of 89 patents.